Related Experiment Videos
Summary
This review examines cardiotoxicity from antitumor treatments like anthracyclines and radiation, including drug interactions. Understanding these risks is crucial for cancer patient care.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Cancer therapies, including anthracycline antibiotics, cyclophosphamide, corticosteroids, 5-fluorouracil, and radiation, can cause cardiotoxic effects.
- The cardiotoxicity may be exacerbated by the concurrent use of other potentially cardiotoxic medications.
Purpose of the Study:
- To review the cardiotoxic effects associated with various antitumor treatments.
- To discuss the mechanisms, interactions, and diagnostic approaches related to cancer therapy-induced cardiotoxicity.
Main Methods:
- Literature review of experimental models and clinical findings.
- Discussion of pathogenetic factors and drug interactions with biological targets.
Main Results:
- Antitumor agents and radiation therapy are associated with significant cardiotoxic risks.
- Interactions between antitumor drugs, biomembranes, DNA, and immune responses contribute to cardiotoxicity.
Conclusions:
- Awareness of potential cardiotoxicity is essential for managing patients undergoing cancer treatment.
- Further research into pathogenetic factors and diagnostic methods can improve patient outcomes.